Fortress Biotech, Inc.FBIONASDAQ

Revenue (LTM)

$58M

-31.8% YoY

Net Income (LTM)

$-46M

+24.1% YoY

Free Cash Flow

$-95M

Revenue CAGR (5Y)

+6.0%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	46	69↑50.9%	76↑10.1%	85↑11.6%	58↓31.8%
Gross Profit	31	37↑18.4%	45↑22.5%	62↑37.0%	37↓40.3%
Operating Income	-94	-189↓100.0%	-204↓8.0%	-142↑30.1%	-110↑22.5%
Net Income	-47	-65↓39.1%	-87↓33.8%	-61↑30.0%	-46↑24.1%
EBITDA	-88	-146↓66.4%	-194↓32.5%	-136↑29.9%	-104↑23.0%
EPS Diluted	-9.75	-11.85↓21.5%	-14.55↓22.8%	-8.47↑41.8%	-2.69↑68.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	233	306↑31.0%	178↓41.7%	81↓54.6%	57↓29.2%
Total Current Assets	266	346↑30.2%	230↓33.5%	117↓49.2%	90↓22.8%
Total Assets	333	397↑18.9%	294↓25.8%	168↓43.1%	144↓13.9%
Total Current Liabilities	52	101↑95.2%	128↑26.4%	85↓33.5%	71↓15.9%
Total Liabilities	136	171↑25.1%	244↑43.2%	166↓32.1%	146↓12.1%
Total Equity	100	109↑8.3%	42↓61.6%	23↓46.0%	23↑0.9%
Total Debt	89	75↓15.8%	127↑69.8%	89↓30.4%	76↓14.3%
Net Debt	-144	-231↓59.9%	-51↑77.9%	8↑115.1%	19↑143.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-84	-117↓39.3%	-179↓53.9%	-128↑28.5%	-80↑37.5%
Capital Expenditure	-7	-16↓128.2%	-3↑81.3%	-8↓165.1%	-15↓85.2%
Free Cash Flow	-91	-133↓46.3%	-182↓37.3%	-136↑25.3%	-95↑30.2%
Stock-Based Comp	13	19↑44.9%	23↑18.0%	17↓25.9%	33↑91.5%
Net Change in Cash	82	73↓10.5%	-127↓274.1%	-98↑23.2%	-25↑74.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance